Skip to content
Smart Scholars🛡 Scholar Shield🏛 Research Integrity Desk🧩 Portfolio Console📰 Journals🔧 DOI MembersTools🔎 Journal AuditGI GetIndexedDr DOI Doctor

10.46243/jst.2020.v5.i4.pp173-187 registered

Formulation, Development and Evaluation of Lopinavir Loaded Polymeric Micelles

Resolves to https://www.jst.org.in/index.php/pub/article/view/568

Held by Longman Publishers (India) · prefix 10.46243 live · DOI address https://doi.org/10.46243/jst.2020.v5.i4.pp173-187

Registered 29 Sep 2026 via crossref · record version 2 · last change 29 Sep 2026, 11:59 PM · record sha256 5d1ad3d55112603f…

Resolve ⬇ Record (JSON) ⬇ Kernel Metadata Declaration (XML) Compare with Crossref Cite (APA · BibTeX · RIS · CSL)

Also as schema.org JSON-LD · Turtle · RDF/XML · DataCite XML (not for this record) · Crossref UNIXREF · Crossref UNIXSD — the formats of the DOI content-negotiation service, from this record (which carries what).

What the DOI identifies

JournalArticle — an article in a journal · Digital · Visual · en

Formulation, Development and Evaluation of Lopinavir Loaded Polymeric Micelles (PrincipalTitle · en)

Published 2020-07-30

Part of Journal of Science & Technology · ISSN 2456-5660 · issue Volume 5 · pages 173–187

Agents

  • Longman Publishers (publisher)

Identifiers DOI 10.46243/jst.2020.v5.i4.pp173-187

Abstract · en

Lopinavir is the anti HIV drug which is used to treat the HIV-1 infection. In this study we used the single lopinavir drug to formulate the polymeric micelle. This study was done with the two main objectives as Objective:first to enhance the solubility and bioavailability of the BCS class IV drug and second to avoid the combination of lopinavir rand ritonavir and use single lopinavir to preparation of polymeric micelle also to avoid the disadvantages related to the oral administration. Method:The different pluronic (F188 &F127) and co-solvent (Tween80) were chosen & the micelles were prepared by using different Drug: polymer ratio with or without cosolvent and drug Lopinavir. Formulations were been characterized by critical micelle concentration(CMC) value, micellesize,DSC, XRD, loading efficiency, % drug loading and stability.Result:Mixed micelle (hydrophobic &hydrophilic) obtained from optimized batch shows the highest entrapment of 29%with the pluronic F68 with the use of co-solvent and the vesicle size of 0.156µm the DSC, FTIR, XRD study was also done for lopinavir and optimized formulation .Conclusion: The pluronic F68 with the co-solvent showed fairly high entrapment efficiency, loading capacity than the mixed Pluronic in combination

Licence https://creativecommons.org/licenses/by/4.0

System metadata — ISO 26324:2025, Annex B · DOI Handbook 10.1

Each element by the standard's name (Annex B: reference elements, then administrative) and the Handbook's (in grey), read off the record above.

ElementValueIn the record
DOI Name
DOI name
10.46243/jst.2020.v5.i4.pp173-187doi
Referent Type
referentType
Creationreferent
Referent Sub-Type
referentSubType
JournalArticle — an article in a journaltype
Referent Name(s)
referentName(s)
Formulation, Development and Evaluation of Lopinavir Loaded Polymeric Micelles (PrincipalTitle, en)titles
Basic Metadata
basicMetadata
publisher: Longman Publishers
published: 2020-07-30
part of: Journal of Science & Technology · ISSN 2456-5660 · no. Volume 5 · pp. 173–187
language: en
form: Digital · Visual · Language
agents, dates, container, language, structural_type, modes, characters
Referent Identifier(s)
alternateIdentifier(s)
none besides the DOIidentifiers, relations (IsSameAs)
Registration Authority
registrationAuthorityCode
Crossref — issued by Crossref (member 25296); held here as a copyrecord.source_agency (our code, ra_doi_name, for names issued here once appointed)
Created Date
issueDate
2020-07-30record.registered (when the DOI name was first registered)
relatedIdentifiersnone needed — the descriptive metadata is in this recordcontainer, relations (only where the descriptive metadata lives at another identifier)

complete Every System Metadata element is here, with the basic metadata a journal article needs.

Recommended for a journal article and not in this record: its author(s), editor(s) or corporate author · the volume number.

The System Metadata Declaration (JSON) · the Kernel Metadata Declaration (XML) · what each sub-type needs

Cited by — in this registry

No record held in this registry cites this DOI.

Counts only records held in this registry; a citation from a work held elsewhere is not seen here. The list as JSON

References with DOIs

The record lists 26 references; 21 carry a DOI.

#ReferenceDOIHeld here
2ref2 Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings.Adv Dru…10.1016/j.addr.2012.09.019not held here
3ref3 Fernandez AM, Van Derpoorten K, Dasnois L. N-Succinyl-(beta-alanyl-Lleucyl-L-alanyl-L-leucyl) doxorubicin: an extra cellularlytumoractivated prodrug devoid of intravenous acute to…10.1021/jm0108754not held here
4ref4 Groneberg DA, Giersig M, Welte T. Nanoparticle-based diagnosis and therapy. Curr Drug targets. 2006; 7: 643-810.2174/138945006777435245not held here
5ref5 Farokhzad OC, Langer R. Nanomedicine: developing smarter therapeutic and diagnostic modalities. Adv Drug Deliv Rev. 2006; 58(14): 1456- 910.1016/j.addr.2006.09.011not held here
6ref6 Aliabadi HM, Lavasanifar A. Polymeric micelles for drug delivery. Expert Opin.Drug Deliv. 2006; 12(36): 139-6210.1517/17425247.3.1.139not held here
7ref7 Gaucher G, Marchessault RH, Leroux JC. Polyester-based micelles and nanoparticles for the parenteral delivery of taxanes. J. Control. Release. 2010; 143(1): 2-1210.1016/j.jconrel.2009.11.012not held here
8ref8 Nakasima K, Bahadur P. Aggregation of water-soluble block copolymers in aqueous solutions: recent trends. Adv. Colloid Interface Sci. 2006; 123: 7510.1016/j.cis.2006.05.016not held here
10ref10 Sezgin Z, Yuksel N, Baykara T. Preparation and characterization of polymeric micelles for solubilization of poorly soluble anticancer drugs. Eur. J. Pharm. Biopharm. 2006; 64(3): …10.1016/j.ejpb.2006.06.011not held here
11ref11 Chiappetta DA, Sosnik A. Poly (ethylene oxide)-poly (propylene oxide) block copolymer micelles as drug delivery agents: improved hydro solubility, stability and bioavailability of…10.1016/j.ejpb.2007.03.022not held here
12ref12 Oh KT, Bronich TK, Kabanov AV. Micellar formulations for drug delivery based on mixtures of hydrophobic and hydrophilic Pluronic block copolymers. J. Control. Release. 2004; 94(2)…10.1016/j.jconrel.2003.10.018not held here
13ref13 Mansur CRE, Barboza SP, González G, Lucas EF. PLURONIC x TETRONIC polyols: study of their properties and performance in the destabilization of emulsions formed in the petroleum in…10.1016/j.jcis.2003.11.034not held here
14ref14 Allen CD, Maysinger A. Eisenberg, Nano-engineering block copolymer aggregates for drug delivery, Coll. Surf. B Biointerf.1999; 16: 1–3510.1016/s0927-7765(99)00058-2not held here
16ref16 Rxlist. Availaible From: URL: www.Rxlist.com. (Assessed on 30th July 2010) 17.Gao ZG, Fain HD, Rapoport N. Controlled and targeted tumor chemotherapy by micellar-encapsulated drug…10.1016/j.jconrel.2004.09.021not held here
17ref17 Sharma, Rakesh, Bahadur P. Effect of different additives on the cloud point of a polyethylene oxide-polypropylene oxide-polyethylene oxide block copolymer in aqueous solution. Jou…10.1007/s11743-002-0226-9not held here
19ref19 SumbulFatma, ReuvenYakubov, Kamran Anwar M, MahmoodHussain. Pluronic L81 enhances triacylglycerol accumulation in the cytosol and inhibits chylomicron secretion. Journal of Lipid …10.1194/jlr.m600211-jlr200not held here
20ref20 Alexandridis P, Hatton TA. Poly (ethylene oxide)-poly-(propylene oxide)poly (ethylene oxide) block copolymer surfactant in aqueous solution and at interfaces: thermodynamics, stru…10.1016/0927-7757(94)03028-xnot held here
22ref22 Ronald Soong, Mu-Ping Nieh, Eric Nicholson, John Katsaras, Peter M, Macdonald. Bicellar mixtures containing pluronic F68: morphology and lateral diffusion from combined SANS and P…10.1021/la902795hnot held here
23ref23 Kadam Y, Bharatiya B, Hassan PA, Verma G, Aswal VK, Bahadur P. Effect of an amphiphilic diol (Surfynol®) on the micellar characteristics of PEO–PPO–PEO block copolymers in aqueous…10.1016/j.colsurfa.2010.04.025not held here
24ref24 Kabanov AV, Alakov VY. Pluronic block copolymers in drug delivery: from micellar nano containers to biological response modifiers, Crit. Rev. Ther. Drug Carrier Syst. 2002; 19(1):…10.1615/critrevtherdrugcarriersyst.v19.i1.10not held here
25ref25 SumbulFatma, ReuvenYakubov, Kamran Anwar M, MahmoodHussain. Pluronic L81 enhances triacylglycerol accumulation in the cytosol and inhibits chylomicron secretion. Journal of Lipid …10.1194/jlr.m600211-jlr200not held here
26ref26 Shilpa micelle as Praveen Chaudhari, Study of block copolymer micelles as vehicle for hydrophobic drug Lamotrigine by Pharmaceutical Research Dec 201410.5530/ijper.48.4s.8not held here

The references as JSON

Relations

The record states no relation, and no record held here states one with this DOI.

The relations as JSON

Funding

The record names no funder.

Each funder's page lists every work held here that names it. ROR IDs open at ror.org; Funder Registry IDs resolve at doi.org.

History — the ledger

Every change to this DOI, in order, as it was recorded. Entries are only ever added, never changed or removed.

#WhenWhatByChanges
129 Sep 2026, 10:00 PMregister
registered at Crossref; record read from api.crossref.org
Administrator (admin) 120 fields set · sha256 a5b36f2834d2…
229 Sep 2026, 11:59 PMupdate
record re-read from api.crossref.org
Administrator (admin)
abstract.value: Lopinavir is the anti HIV drug which is used to treat the HIV-1 infection. In this study we used the single lopinavir drug to formulate the polymeric micelle. This study was done with the two main objectives as Objective:first to enhance the solubility and bioavailability of the BCS class IV drug and second to avoid the combination of lopinavir rand ritonavir and use single lopinavir to preparation of polymeric micelle also to avoid the disadvantages related to the oral administration. Method:The different pluronic (F188 &F127) and co-solvent (Tween80) were chosen & the micelles were prepared by using different Drug: polymer ratio with or without cosolvent and drug Lopinavir. Formulations were been characterized by critical micelle concentration(CMC) value, micellesize,DSC, XRD, loading efficiency, % drug loading and stability.Result:Mixed micelle (hydrophobic &hydrophilic) obtained from optimized batch shows the highest entrapment of 29%with the pluronic F68 with the use of co-solvent and the vesicle size of 0.156µm the DSC, FTIR, XRD study was also done for lopinavir and optimized formulation .Conclusion: The pluronic F68 with the co-solvent showed fairly high entrapment efficiency, loading capacity than the mixed Pluronic in combination → Lopinavir is the anti HIV drug which is used to treat the HIV-1 infection. In this study we used the single lopinavir drug to formulate the polymeric micelle. This study was done with the two main objectives as Objective:first to enhance the solubility and bioavailability of the BCS class IV drug and second to avoid the combination of lopinavir rand ritonavir and use single lopinavir to preparation of polymeric micelle also to avoid the disadvantages related to the oral administration. Method:The different pluronic (F188 &F127) and co-solvent (Tween80) were chosen & the micelles were prepared by using different Drug: polymer ratio with or without cosolvent and drug Lopinavir. Formulations were been characterized by critical micelle concentration(CMC) value, micellesize,DSC, XRD, loading efficiency, % drug loading and stability.Result:Mixed micelle (hydrophobic &hydrophilic) obtained from optimized batch shows the highest entrapment of 29%with the pluronic F68 with the use of co-solvent and the vesicle size of 0.156µm the DSC, FTIR, XRD study was also done for lopinavir and optimized formulation .Conclusion: The pluronic F68 with the co-solvent showed fairly high entrapment efficiency, loading capacity than the mixed Pluronic in combination
container.titles.0.value: Journal of Science & Technology → Journal of Science & Technology
titles.0.value: Formulation, Development and Evaluation of Lopinavir Loaded Polymeric Micelles → Formulation, Development and Evaluation of Lopinavir Loaded Polymeric Micelles

Machine-readable: the history as JSON, with the full record after each change.

Changes made at Crossref through DOI Doctor

Every deposit Smart Scholars' DOI Doctor made for this DOI, oldest first, with Crossref's own answer. Each fingerprint is the SHA-256 of its entry and of the fingerprint before it, so a change to any earlier entry changes every fingerprint after it.

WhenWhat changedCrossrefFingerprint
06 Nov 2026, 13:49Metadata completed
the record's metadata
● waiting for Crossref's answerbaeb87d6e744…
06 Nov 2026, 14:11Read back: Crossref's record shows it● confirmed72136ad0c232…

2 entries · the last fingerprint 72136ad0c2322329c67451bdc35f756f42970bcbedbf91e5234bc287416126f9 · the history as JSON, each entry with the fingerprint before it, to check them yourself.

Share this page

Share this page

Ask AI about this page

Everything Smart Scholars runs

Nine sites, one account. A journal starts at the audit; an author starts at Scholar Shield.

What we do: DOIs registered from what a journal already has · Crossref records completed — references, abstracts, licences, ORCID iDs, affiliations and ROR IDs, funding · DOIs that resolve · articles preserved · journals rated on the public record · see everything we do →

Book a free call

For journals & publishers

Start with the audit — ₹4,999 per journal, and the gate to everything else.

DOI care

Every service on one journal profile — each previews first and acts only on your approval.

  • DOI Doctor — check & repairevery DOI tested at doi.org and Crossref; dead links, abstracts, licences, ORCIDs
  • Smart Deposita new DOI from your PDF, Word file, article page, JATS XML or spreadsheet — every value shown with its source, deposited once you confirm it
  • DOI census (Excel)site against Crossref, both directions, with a copy-paste fix per article
  • Backfile DOIsDOIs for older articles that never had one — no per-DOI fee of ours
  • DOIs for conference proceedingsthe conference, the volume and every paper — registered in the organiser's own name
  • Scopus indexing guidethe minimum criteria, the 14 CSAB criteria and how a title is suggested — from Elsevier's own page
  • Embase indexing guidewhat Embase asks of a biomedical journal and how to suggest it
  • Write DOIs into OJSthe verified DOIs pushed onto your article pages through your own API
  • Silent-failure monitorweekly checks of site, OAI-PMH, Scholar tags, ISSN, preservation, hijack lists
  • Journal Radarevery journal, every day: SSL, DNS, redirects, robots.txt, OJS, DOIs, Crossref metadata, broken links — what broke since yesterday first
  • Verified metrics & badgesa public, dated, source-linked metrics page and a "cited by" badge
  • Quality dossier (PDF)one PDF for universities, authors and reviewers
  • Author citation enginethe citation steps emailed to each author from the journal's own mailbox
  • JATS XMLmachine-readable JATS per article
  • Duplicate articlesthe same paper published twice — you choose which copy stays

For authors & researchers

Free to use. Nothing you check is shared with the journal.

For institutions, sponsors & DOI operators

Smart Scholars

Mon–Sat, 10:00–19:00 IST. The Ask AI button on every page answers about our services at any hour.

News

Policies

What we can register a DOI for

20 kinds of record, one account, one place. Every one gets a DOI that resolves, metadata that indexes read, and a record that stays correct afterwards.

Journals

  • Journal articles
  • Journal titles
  • Pending publications
  • Peer reviews
  • Preprints & posted content

Books & conferences

  • Books
  • Book chapters
  • Book series
  • Book sets
  • Conference proceedings
  • Proceedings series
  • Conference papers

Other research output

  • Theses & dissertations
  • Reports & working papers
  • Report series
  • Standards
  • Databases
  • Datasets
  • Figures, tables & supplements

Funding

  • Grants & funding awards

Elsewhere

The same company, in the places our publishers already read.
Add Smart Scholars as a preferred source on GoogleSee more of our newsroom in Google’s Top Stories.
Smart Scholars · Every service on one pageNewsroom posts CC BY 4.0 · DOI metadata CC0 · everything else ©Data from OpenAlex (openalex.org), CC0 · Crossref · ISSN Portal · DOAJContact
WhatsApp